LeMaitre Vascular, Inc. (LMAT) Financials

LMAT Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 629.5 million 222.9 million
Dec. 31, 2025 615.7 million 222.2 million
Sept. 30, 2025 598.1 million 219.1 million
June 30, 2025 577.6 million 214.9 million

LMAT Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 12.3 million 2.1 million
Dec. 31, 2025 21.4 million 2.1 million
Sept. 30, 2025 26.5 million 1.7 million
June 30, 2025 18.9 million 1.9 million

LMAT Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 15.7 million
Dec. 31, 2025 15.6 million
Sept. 30, 2025 17.4 million
June 30, 2025 13.8 million

LMAT Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 367.2 million 186.4 million 20.9 million
Dec. 31, 2025 359.1 million 182.6 million 16.9 million
Sept. 30, 2025 343.1 million 168.4 million 14.4 million
June 30, 2025 319.5 million 168.2 million 17.7 million

LMAT Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 23.0 million
Dec. 31, 2025 23.0 million
Sept. 30, 2025 24.4 million
June 30, 2025 22.9 million

LMAT Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 2.8 million 4.1 million 26.6 million 14.5 million
Dec. 31, 2025 1.8 million 3.5 million 23.8 million 13.4 million
Sept. 30, 2025 2.3 million 3.0 million 22.7 million 11.9 million
June 30, 2025 1.3 million 3.5 million 25.3 million 14.9 million

LMAT Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 66.6 million 18.2 million
Dec. 31, 2025 64.5 million 18.3 million
Sept. 30, 2025 61.0 million 15.1 million
June 30, 2025 64.2 million 19.3 million

LMAT Revenue by Segment
Graph available only for paid members. Upgrade to see it.

LMAT

List: Contenders

Price: $98.81

52 week price:
79.01
118.01

Dividend Yield: 0.87%

5-year range yield:
0.67%
1.16%

Forward Dividend Yield: 0.99%

Payout Ratio: 38.32%

Payout Ratio Range:
-263.53%
484.38%

Dividend Per Share: 1.00 USD

Earnings Per Share: 2.72 USD

P/E Ratio: 37.37

Exchange: NGM

Sector: Healthcare

Industry: Medical Instruments & Supplies

Country: United States

Volume: 56800

Ebitda: 6.1 million

Market Capitalization: 2.4 billion

Average Dividend Frequency: 4

Years Paying Dividends: 16

DGR3: 15.32%

DGR5: 14.90%

DGR10: 17.06%

Links: